Archives of Pharmacal Research

Papers
(The H4-Index of Archives of Pharmacal Research is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Mouse models of nonalcoholic steatohepatitis and their application to new drug development166
Ginsenoside-Rg2 exerts anti-cancer effects through ROS-mediated AMPK activation associated mitochondrial damage and oxidation in MCF-7 cells132
Renal tubular PAR2 promotes interstitial fibrosis by increasing inflammatory responses and EMT process95
Amyloidogenic, neuroinflammatory and memory dysfunction effects of HIV-1 gp12065
CD48-expressing non-small-cell lung cancer cells are susceptible to natural killer cell–mediated cytotoxicity64
Correction to: Recent advances in CRISPR technologies for genome editing53
Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation52
Osteogenic effect of an adiponectin-derived short peptide that rebalances bone remodeling: a potential disease-modifying approach for postmenopausal osteoporosis therapy50
Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities49
Correction to: The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer48
Donepezil improves skeletal muscle insulin resistance in obese mice via the AMPK/FGF21-mediated suppression of inflammation and ferroptosis45
Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin44
Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directions43
Impact of binge drinking on alcoholic liver disease40
Challenges and opportunities of developing small-molecule therapies for age-related macular degeneration40
Prenylated flavonoid fractions from Glycyrrhiza glabra alleviate insulin resistance in HepG2 cells by regulating the ERK/IRS-1 and PI3K/Akt signaling pathways36
Retraction Note: Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats36
Myriocin suppresses tumor growth by modulating macrophage polarization and function through the PI3K/Akt/mTOR pathway35
Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases34
Regulation of NOX/p38 MAPK/PPARα pathways and miR-155 expression by boswellic acids reduces hepatic injury in experimentally-induced alcoholic liver disease mouse model: novel mechanistic insight33
The role and application of transcriptional repressors in cancer treatment32
Advances in plant-derived natural products for antitumor immunotherapy32
Minor structural changes, major functional impacts: posttranslational modifications and drug targets31
A review on bacteria-derived antioxidant metabolites: their production, purification, characterization, potential applications, and limitations30
Non-alcoholic fatty liver disease and liver secretome30
Isolation, structure elucidation, total synthesis, and biosynthesis of dermazolium A, an antibacterial imidazolium metabolite of a vaginal bacterium Dermabacter vaginalis29
Recent advances on Pestalotiopsis genus: chemistry, biological activities, structure–activity relationship, and biosynthesis28
Naringin promotes fat browning mediated by UCP1 activation via the AMPK signaling pathway in 3T3-L1 adipocytes28
0.086981058120728